A nurse is working with a woman who has been diagnosed with severe fibrocystic breast disease. After describing the medications that can be used as treatment, the nurse determines that additional teaching is needed when the client identifies which drug is being used.

Choice A: A 26-year-old client who has migraine headaches at the start of each menstrual cycle does not have a contraindication for receiving oral contraceptives. Oral contraceptives are pills that contain synthetic hormones (estrogen and progestin) that prevent ovulation and pregnancy. They can also help regulate menstrual cycles and reduce menstrual pain and bleeding. Some women with migraine headaches may benefit from oral contraceptives, especially if their migraines are related to hormonal fluctuations or menstruation. However, oral contraceptives may worsen migraines in some women, especially if they have aura (visual or sensory disturbances) or other risk factors for stroke. Therefore, oral contraceptives should be used with caution and under medical supervision in women with migraine headaches.

Choice B: A 28-year-old client who has a history of pelvic inflammatory disease does not have a contraindication for receiving oral contraceptives. Pelvic inflammatory disease (PID) is an infection of the female reproductive organs (uterus, fallopian tubes, ovaries) that can cause pain, fever, discharge, or infertility. It can be caused by various bacteria, often sexually transmitted ones such as gonorrhea or chlamydia. Oral contraceptives do not protect against STIs or PID, but they may reduce the risk of PID by thickening the cervical mucus and preventing bacteria from entering the uterus. Therefore, oral contraceptives can be used safely in women with a history of PID, but they should also use condoms or other barrier methods to prevent STIs.

Choice C: A 32-year-old client who has benign breast disease does not have a contraindication for receiving oral contraceptives. Benign breast disease (BBD) is a term that refers to various noncancerous conditions that affect the breast tissue, such as cysts, fibroadenomas, or mastitis. They can cause symptoms such as lumps, pain, or tenderness in the breasts. Oral contraceptives do not cause or increase the risk of BBD, but they may improve some symptoms of BBD by stabilizing the hormonal levels and reducing breast tissue sensitivity. Therefore, oral contraceptives can be used safely in women with BBD, but they should also have regular breast exams and mammograms to monitor their breast health.

Choice D: A 38-year-old client who reports smoking one pack of cigarettes every day has a contraindication for receiving oral contraceptives. Smoking is a habit that involves inhaling the smoke of tobacco or other substances that can cause various health problems, such as lung cancer, heart disease, or stroke. Oral contraceptives can increase the risk of these problems, especially in women who are older than 35 years or smoke more than 15 cigarettes per day. Smoking and oral contraceptives can interact and cause blood clots, high blood pressure, or reduced blood flow to the organs. Therefore, oral contraceptives should be avoided or discontinued in women who smoke, and alternative methods of contraception should be used.

Choice A: Bleeding between menses is not the correct answer because it is not a specific clinical manifestation of endometrial polyps. Bleeding between menses is a condition that causes spotting or bleeding at any time other than during the normal menstrual period. It can be caused by various factors such as hormonal imbalance, infection, or pregnancy. It can also occur in some women with endometrial polyps, but it is not a definitive sign of them.

Choice B: Bleeding after intercourse is not the correct answer because it is not a specific clinical manifestation of endometrial polyps. Bleeding after intercourse is a condition that causes bleeding from the vagina or cervix after sexual activity. It can be caused by various factors such as trauma, infection, or cancer. It can also occur in some women with endometrial polyps, but it is not a definitive sign of them.

Choice C: Metrorrhagia is the correct answer because it is a specific clinical manifestation of endometrial polyps. Metrorrhagia is a condition that causes irregular or excessive bleeding from the uterus that is unrelated to the menstrual cycle. It can be caused by various factors such as polyps, fibroids, or cancer. It is a common symptom of endometrial polyps, which are benign growths of the endometrium (the lining of the uterus) that can protrude into the uterine cavity and cause bleeding.

Choice D: Vaginal discharge is not the correct answer because it is not a specific clinical manifestation of endometrial polyps. Vaginal discharge is a fluid that comes out of the vagina and varies in color, consistency, and odor depending on the phase of the menstrual cycle, sexual activity, or health status. It can be caused by various factors such as normal secretions, infection, or inflammation. It is not a common symptom of endometrial polyps, which do not usually affect the vaginal flora or pH.